APA (7th ed.) Citation

C, L., C, S., Y, H., Y, D., Y, L., D, L., . . . W, W. (2026). Integrated multi-omics and single-cell analyses identify metabolic heterogeneity and therapeutic vulnerabilities in medullary thyroid cancer. British journal of cancer, 135(4), 546. https://doi.org/10.1038/s41416-026-03467-1

Chicago Style (17th ed.) Citation

C, Liu, et al. "Integrated Multi-omics and Single-cell Analyses Identify Metabolic Heterogeneity and Therapeutic Vulnerabilities in Medullary Thyroid Cancer." British Journal of Cancer 135, no. 4 (2026): 546. https://doi.org/10.1038/s41416-026-03467-1.

MLA (9th ed.) Citation

C, Liu, et al. "Integrated Multi-omics and Single-cell Analyses Identify Metabolic Heterogeneity and Therapeutic Vulnerabilities in Medullary Thyroid Cancer." British Journal of Cancer, vol. 135, no. 4, 2026, p. 546, https://doi.org/10.1038/s41416-026-03467-1.